250 related articles for article (PubMed ID: 10069421)
21. The T cell receptor repertoire of CD8+CD28- T lymphocytes is dominated by expanded clones that persist over time.
Mugnaini EN; Egeland T; Spurkland A; Brinchmann JE
Clin Exp Immunol; 1999 Aug; 117(2):298-303. PubMed ID: 10444261
[TBL] [Abstract][Full Text] [Related]
22. Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression.
Meng Y; Harlin H; O'Keefe JP; Gajewski TF
J Immunol; 2006 Aug; 177(3):1981-7. PubMed ID: 16849512
[TBL] [Abstract][Full Text] [Related]
23. Functional subsets of CD4 T cells in rheumatoid synovitis.
Namekawa T; Wagner UG; Goronzy JJ; Weyand CM
Arthritis Rheum; 1998 Dec; 41(12):2108-16. PubMed ID: 9870867
[TBL] [Abstract][Full Text] [Related]
24. Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.
Labalette M; Leteurtre E; Thumerelle C; Grutzmacher C; Tourvieille B; Dessaint JP
Int Immunol; 1999 Aug; 11(8):1327-36. PubMed ID: 10421790
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.
Borthwick NJ; Bofill M; Gombert WM; Akbar AN; Medina E; Sagawa K; Lipman MC; Johnson MA; Janossy G
AIDS; 1994 Apr; 8(4):431-41. PubMed ID: 8011246
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.
Rufer N; Zippelius A; Batard P; Pittet MJ; Kurth I; Corthesy P; Cerottini JC; Leyvraz S; Roosnek E; Nabholz M; Romero P
Blood; 2003 Sep; 102(5):1779-87. PubMed ID: 12750165
[TBL] [Abstract][Full Text] [Related]
27. In vivo expansion coincident with excessive in vitro cell death within the memory subset of CD8+ T cells in HIV type 1 infection.
Mugnaini EN; Haaheim LL; Sannes M; Brinchmann JE
AIDS Res Hum Retroviruses; 1999 Feb; 15(3):265-72. PubMed ID: 10052757
[TBL] [Abstract][Full Text] [Related]
28. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
[TBL] [Abstract][Full Text] [Related]
29. Homeostatic regulation of CD8+ T cells by perforin.
Kägi D; Odermatt B; Mak TW
Eur J Immunol; 1999 Oct; 29(10):3262-72. PubMed ID: 10540338
[TBL] [Abstract][Full Text] [Related]
30. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
31. The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
Speiser DE; Colonna M; Ayyoub M; Cella M; Pittet MJ; Batard P; Valmori D; Guillaume P; Liénard D; Cerottini JC; Romero P
J Immunol; 2001 Dec; 167(11):6165-70. PubMed ID: 11714776
[TBL] [Abstract][Full Text] [Related]
32. Oligoclonal expansions in the CD8(+)CD28(-) T cells largely explain the shorter telomeres detected in this subset: analysis by flow FISH.
Batliwalla FM; Rufer N; Lansdorp PM; Gregersen PK
Hum Immunol; 2000 Oct; 61(10):951-8. PubMed ID: 11082508
[TBL] [Abstract][Full Text] [Related]
33. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment.
Sze DM; Giesajtis G; Brown RD; Raitakari M; Gibson J; Ho J; Baxter AG; Fazekas de St Groth B; Basten A; Joshua DE
Blood; 2001 Nov; 98(9):2817-27. PubMed ID: 11675356
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation.
Kobayashi N; Takata H; Yokota S; Takiguchi M
Eur J Immunol; 2004 Dec; 34(12):3370-8. PubMed ID: 15549771
[TBL] [Abstract][Full Text] [Related]
35. Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients.
Dalod M; Sinet M; Deschemin JC; Fiorentino S; Venet A; Guillet JG
Eur J Immunol; 1999 Jan; 29(1):38-44. PubMed ID: 9933084
[TBL] [Abstract][Full Text] [Related]
36. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
37. Death by neglect as a deletional mechanism of peripheral tolerance.
Bertolino P; Trescol-Biémont MC; Thomas J; Fazekas de St Groth B; Pihlgren M; Marvel J; Rabourdin-Combe C
Int Immunol; 1999 Aug; 11(8):1225-38. PubMed ID: 10421780
[TBL] [Abstract][Full Text] [Related]
38. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Tsukishiro T; Donnenberg AD; Whiteside TL
Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
[TBL] [Abstract][Full Text] [Related]
39. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis.
Borthwick NJ; Lowdell M; Salmon M; Akbar AN
Int Immunol; 2000 Jul; 12(7):1005-13. PubMed ID: 10882412
[TBL] [Abstract][Full Text] [Related]
40. Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
Roos MT; van Lier RA; Hamann D; Knol GJ; Verhoofstad I; van Baarle D; Miedema F; Schellekens PT
J Infect Dis; 2000 Aug; 182(2):451-8. PubMed ID: 10915075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
